Northern Trust Company of Connecticut’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Northern Trust Company of Connecticut’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$1.49M	Sell	218,270 -1,113	-0.5%	-$6.01K	0.01%	1202
2013 Q3	$4.04M	Buy	219,383 +3,973	+2%	+$77.1K	0.03%	771
2013 Q2	$3.77M	Buy	+215,410	New	+$3.82M	0.03%	762

Other funds holding ARIA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Northern Trust Company of Connecticut's ARIA Position: Q4 2013 in Review

Northern Trust Company of Connecticut reduced its Ariad Pharmaceuticals Inc (ARIA) stake by 0.51% in Q4 2013, selling an estimated $6.01K and leaving 218,270 shares worth $1.49M. The position accounts for 0.01% of the portfolio, ranked #1202.

Northern Trust Company of Connecticut first reported a position in ARIA in Q2 2013 and has held it in 3 quarters since. The position peaked at $4.04M in Q3 2013. 166 funds tracked by Wall St. Rank hold ARIA as of Q4 2013.

Northern Trust Company of Connecticut held 218,270 shares of Ariad Pharmaceuticals Inc worth $1.49M as of Q4 2013.
Northern Trust Company of Connecticut sold 1,113 Ariad Pharmaceuticals Inc shares in Q4 2013, an estimated $6.01K.
Ariad Pharmaceuticals Inc made up 0.01% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #1202 holding.
Northern Trust Company of Connecticut first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and has held it in 3 quarters since.
Northern Trust Company of Connecticut's Ariad Pharmaceuticals Inc position peaked at $4.04M in Q3 2013.
166 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.